Board Meeting

ALKEM LABORATORIES LTD.

NSE : ALKEMBSE : 539523ISIN CODE : INE540L01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE5425.85-63.65 (-1.16 %)
PREV CLOSE ( ) 5489.50
OPEN PRICE ( ) 5489.95
BID PRICE (QTY) 5422.35 (1)
OFFER PRICE (QTY) 5430.00 (5)
VOLUME 417
TODAY'S LOW / HIGH ( )5408.25 5525.45
52 WK LOW / HIGH ( )4409.9 6440
NSE5433.75-56.2 (-1.02 %)
PREV CLOSE( ) 5489.95
OPEN PRICE ( ) 5529.45
BID PRICE (QTY) 5433.75 (1)
OFFER PRICE (QTY) 5436.10 (37)
VOLUME 81079
TODAY'S LOW / HIGH( ) 5405.50 5535.00
52 WK LOW / HIGH ( )4407.05 6439.9

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.